FLAP inhibitor (Amira)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFLAP inhibitor (Amira)
Drug Alias Name5-lipoxygenase activating protein inhibitor (Amira)AM-802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5-lipoxygenase activating protein inhibitors
Targets5-lipoxygenase activating protein
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmira Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmira Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A